[1] Fabbri M,Croce CM,Calin GA,et al. MicroRNAs [J]. Cancer J,2008V14N1∶1-6
[2] Skaftnesmo KO,Prestegarden L,Micklem DR,et al. MicroRNAs in tumorigenesis [J]. Curr Pharm Biotechnol,2007V8N6∶320-5
[3] Ebert MS,Sharp PA.MicroRNA sponges:progress and possibilities [J]. RNA,2010V16N11∶2043-50
[4] Calin GA,Sevignani C,Dumitru CD,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J]. Proc Natl Acad Sci USA,2004V101N9∶2999-3004
[5] Kredo-Russo S,Ness A,Mandelbaum AD,et al. Regulation of pancreatic microRNA-7 expression [J]. Exp Diabetes Res,2012V2012N∶695214
[6] Xiong S,Zheng Y,Jiang P,et al. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer [J]. Br J Cancer,2014V110N2∶353-62
[7] Yu N,Huangyang P,Yang X,et al.microRNA-7suppresses the invasive potential ofbreast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8 [J]. J Biol Chem,2013V288N27∶19633-42
[8] Hansen TB,Kjems J,Damgaard CK,et al. Circular RNA and miR-7 in Cancer [J]. Cancer Res,2013V73N18∶5609-12
[9] Li YJ, Wang CH, Zhou Y, et al. TLR9sig-nalingrepressedtumor suppressormiR-7 expression through up-regulation of HuR in human lung cancer cells [J]. Cancer Cell Int, 2013V13N1∶90
[10] Kefas B,Godlewski J,Comeau L,et al. microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma [J]. Cancer Res, 2008V68N10∶3566-72
[11] Baba Y,Fujii M,Tokumaru Y,et al. Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer [J]. J Oncol,2012V2012N∶986725
[12] Chung CH,Ely K,McGavran L,et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas [J]. J Clin Oncol,2006V24N25∶4170-6
[13] Bonner JA,Harari PM,Giralt J,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J]. N Engl J Med,2006V354N6∶567-78
[14] Vermorken JB,Mesia R,Rivera F,et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer [J]. N Engl J Med,2008V359N11∶1116-27
[15] Kalinowski FC,Giles KM,Candy PA,et al. Regulationofepidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancercells by miR-7 [J]. PLoS One,2012V7N10∶e47067
[16] Jemal A, Bray F, Center MM, et al. Global Cancer Statistics [J]. CA Cancer J Clin,2011V61N2∶69-90
[17] Rossi L,Zoratto F,Papa A,et al. Current approach in the treatment of hepatocellular carcinoma [J]. World J Gastrointest Oncol,2010V2N9∶348-59
[18] Fang Y,Xue JL,Shen Q,et al. MicroRNA-7 Inhibits Tumor Growth and Metastasis by Targeting the PI3K/Akt Pathway in hepatocellular carcinoma [J]. Hepatology,2012V55N6∶1852-62
[19] Yu Z,Ni L,Chen D,et al. Identification of miR-7 as an oncogene in renal cell carcinoma [J]. J Mol Histol,2013V44N6∶669-77 |
